Ignite Creation Date:
2024-05-06 @ 11:43 AM
Last Modification Date:
2024-10-26 @ 12:49 PM
Study NCT ID:
NCT03585686
Status:
RECRUITING
Last Update Posted:
2023-03-16
First Post:
2018-07-06
Brief Title:
A Combination of Vemurafenib Cytarabine and 2-chlorodeoxyadenosine in Children With LCH and BRAF V600E Mutation
Sponsor:
Federal Research Institute of Pediatric Hematology Oncology and Immunology
Organization:
Federal Research Institute of Pediatric Hematology Oncology and Immunology
Key Dates - Follows AllAPIJSON File Order
Start Date:
2018-06-26
Start Date Type:
ACTUAL
Primary Completion Date:
2023-04
Primary Completion Date Type:
ESTIMATED
Completion Date:
2023-12
Completion Date Type:
ESTIMATED
First Submit Date:
2018-07-06
First Submit QC Date:
July 6 2018
Study First Post Date:
2018-07-13
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-03-15
Last Update Post Date:
2023-03-16
Last Update Post Date Type:
ACTUAL